Haddad Hannah Waleed, Mallepalli Nikita Reddy, Scheinuk John Emerson, Bhargava Pranav, Cornett Elyse M, Urits Ivan, Kaye Alan David
Kansas City University of Medicine and Biosciences, Kansas City, MO, USA.
Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA, USA.
Pain Ther. 2021 Dec;10(2):827-848. doi: 10.1007/s40122-021-00266-9. Epub 2021 Apr 28.
The multifaceted clinical presentation of fibromyalgia (FM) supports the modern understanding of the disorder as a more global condition than one simply affecting pain sensation. The main pharmacologic therapies used clinically include anti-epileptics and anti-depressants. Conservative treatment options include exercise, myofascial release, psychotherapy, and nutrient supplementation.
Narrative review.
Nutrient supplementation is a broadly investigated treatment modality as numerous deficiencies have been linked to FM. Additionally, a proposed link between gut microbiome patterns and chronic pain syndromes has led to studies investigating probiotics as a possible treatment. Despite positive results, much of the current evidence regarding this topic is of poor quality, with variable study designs, limited sample sizes, and lack of control groups.
The etiology of FM is complex, and has shown to be multi-factorial with genetics and environmental exposures lending influence into its development. Preliminary results are promising, however, much of the existing evidence regarding diet supplementation is of poor quality. Further, more robust studies are needed to fully elucidate the potential of this alternative therapeutic option.
纤维肌痛(FM)的多方面临床表现支持了现代对该疾病的理解,即它是一种比单纯影响痛觉更为全身性的病症。临床上使用的主要药物疗法包括抗癫痫药和抗抑郁药。保守治疗选择包括运动、肌筋膜放松、心理治疗和营养补充。
叙述性综述。
营养补充是一种经过广泛研究的治疗方式,因为许多营养素缺乏都与纤维肌痛有关。此外,肠道微生物群模式与慢性疼痛综合征之间的假定联系促使人们研究益生菌作为一种可能的治疗方法。尽管取得了积极成果,但目前关于这一主题的许多证据质量较差,研究设计各异,样本量有限,且缺乏对照组。
纤维肌痛的病因复杂,已证明是多因素的,遗传因素和环境暴露都会影响其发展。初步结果很有前景,然而,现有关于饮食补充的许多证据质量较差。此外,需要更有力的研究来充分阐明这种替代治疗选择的潜力。